Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
347 JPY | 0.00% |
|
-0.57% | -20.05% |
Business Summary
Number of employees: 4
Sales per Business
JPY in Million | 2023 | Weight | 2024 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceuticals, Medical Devices, and Programmed Medical Devices
100.0
%
| 101 | 100.0 % | 194 | 100.0 % | +93.11% |
Sales per region
JPY in Million | 2023 | Weight | 2024 | Weight | Delta |
---|---|---|---|---|---|
Japan
100.0
%
| 101 | 100.0 % | 101 | 100.0 % | 0.00% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Koji Naito
PSD | President | 65 | 18-12-31 |
Sho Kato
CTO | Chief Tech/Sci/R&D Officer | 36 | 18-04-30 |
Kazuhiro Ikeda
ADM | Chief Administrative Officer | 68 | 19-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Yasuo Azuma
BRD | Director/Board Member | 76 | 19-03-31 |
Kazuhiro Ikeda
ADM | Chief Administrative Officer | 68 | 19-12-31 |
Toshio Miyata
CHM | Chairman | 63 | 18-03-31 |
Koji Naito
PSD | President | 65 | 18-12-31 |
Sho Kato
CTO | Chief Tech/Sci/R&D Officer | 36 | 18-04-30 |
Mitsuru Ichikawa
BRD | Director/Board Member | 64 | 19-09-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 12,711,700 | 6,130,800 ( 48.23 %) | 0 | 48.23 % |
Company contact information
Renascience, Inc.
Kyodo Building 401 2-3-6 Nihonbashi Honcho
103-0023, Tokyo
+
http://www.renascience.co.jp![address Renascience Inc.(4889)](https://cdn.zonebourse.com/static/address/127218893.png)
Sector
1st Jan change | Capi. | |
---|---|---|
-20.05% | 27.94M | |
+63.05% | 856B | |
+39.42% | 631B | |
-4.78% | 359B | |
+17.52% | 325B | |
+8.43% | 297B | |
+14.19% | 244B | |
+5.81% | 234B | |
+16.77% | 226B | |
+14.63% | 177B |
- Stock Market
- Equities
- 4889 Stock
- Company Renascience Inc.